Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2

Status

Completed 12Active not recruiting 6Unknown 4Recruiting 3Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 5NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 6

Conditions

Prostatic Neoplasms 21Breast Neoplasms 6Prostate Adenocarcinoma 2Salivary Gland Neoplasms 1PSA Level Greater Than Two 1Neoplasms 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Leukemia 1Hormone Sensitive Prostate Cancer 1Granulosa cell tumor of the ovary 1Castration-resistant Prostate Cancer Patients with Oligometastases 1Breast Neoplasms, Male 1

Interventions

Paclitaxel 62Letrozole 55Fulvestrant 55Trastuzumab 50palbociclib 41pembrolizumab 37Cyclophosphamide 37Carboplatin 37Anastrozole 37pertuzumab 35exemestane 25Tamoxifen 24Capecitabine 24ribociclib 23abemaciclib 23Radiotherapy 21Docetaxel 21olaparib 20Doxorubicin 20Magnetic Resonance Spectroscopy 19trastuzumab deruxtecan 17Surveys and Questionnaires 17durvalumab 16Epirubicin 16Specimen Handling 14Exercise 14130-nm albumin-bound paclitaxel 14Taxes 13Alpelisib 13Goserelin 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Active not recruiting × Breast Neoplasms × Leuprolide × Clear all
NCT04569747 2026-04-02

ADEPT

Dana-Farber Cancer Institute

Phase 2 Active not recruiting
393 enrolled
Breast

Breast Neoplasms

NCT04293393 2026-03-12

CARABELA

Spanish Breast Cancer Research Group

Phase 2 Active not recruiting
200 enrolled 27 charts
Breast

Breast Neoplasms

NCT01674140 2026-02-10

e3

SWOG Cancer Research Network

Phase 3 Active not recruiting
1,939 enrolled 15 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT03944434 2025-02-26

FACILE

Fondazione Sandro Pitigliani

Phase 2 Active not recruiting
116 enrolled
Breast

Breast Neoplasms

NCT03900637 2024-07-31

PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate

Seoul National University Hospital

Phase 2 Active not recruiting
122 enrolled
Breast

Breast Neoplasms

NCT02344472 2024-06-04

Detect V / CHEVENDO (Chemo vs. Endo)

University of Ulm

Phase 3 Active not recruiting
271 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡